2
Clinical Trials associated with BCG Vaccine(Chengdu Coen Biotechnology)Phase III Multi-center Randomized, Double-blind and Positive-controlled Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
A phase III multi-center randomized, double-blind and positive-controlled clinical trial for evaluating the efficacy and safety of BCG for Therapeutic Use(BCG) in the prevention of postoperative recurrence of medium/high-risk non-muscle invasive bladder cancer (NMIBC).
A Phase I Clinical Study to Investigate the Safety and Tolerance of Therapeutic Bacillus Calmette-Guerin( BCG) in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)
Phase I clinical study to investigate the safety and tolerance of therapeutic BCG in postoperative adjuvant therapy in subjects with moderate to high-risk non-muscular invasive bladder cancer (NMIBC)
100 Clinical Results associated with BCG Vaccine(Chengdu Coen Biotechnology)
100 Translational Medicine associated with BCG Vaccine(Chengdu Coen Biotechnology)
100 Patents (Medical) associated with BCG Vaccine(Chengdu Coen Biotechnology)
100 Deals associated with BCG Vaccine(Chengdu Coen Biotechnology)